Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Vasodilators Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Arterial Dilators
  • 1.3.3 Venous Dilators
  • 1.3.4 Mixed Dilators
• 1.4 Market Segment by Application
  • 1.4.1 Global Vasodilators Market Share by Application (2019-2025)
  • 1.4.2 Hypertension
  • 1.4.3 Angina
  • 1.4.4 Heart Failure
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Vasodilators Market Size
  • 2.1.1 Global Vasodilators Revenue 2014-2025
  • 2.1.2 Global Vasodilators Sales 2014-2025
• 2.2 Vasodilators Growth Rate by Regions
  • 2.2.1 Global Vasodilators Sales by Regions 2014-2019
  • 2.2.2 Global Vasodilators Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Vasodilators Sales by Manufacturers
  • 3.1.1 Vasodilators Sales by Manufacturers 2014-2019
  • 3.1.2 Vasodilators Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Vasodilators Revenue by Manufacturers (2014-2019)
  • 3.2.2 Vasodilators Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Vasodilators Market Concentration Ratio (CR5 and HHI)
• 3.3 Vasodilators Price by Manufacturers
• 3.4 Key Manufacturers Vasodilators Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Vasodilators Market
• 3.6 Key Manufacturers Vasodilators Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Arterial Dilators Sales and Revenue (2014-2019)
  • 4.1.2 Venous Dilators Sales and Revenue (2014-2019)
  • 4.1.3 Mixed Dilators Sales and Revenue (2014-2019)
• 4.2 Global Vasodilators Sales Market Share by Type
• 4.3 Global Vasodilators Revenue Market Share by Type
• 4.4 Vasodilators Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Vasodilators Sales by Application

6 United States

• 6.1 United States Vasodilators Breakdown Data by Company
• 6.2 United States Vasodilators Breakdown Data by Type
• 6.3 United States Vasodilators Breakdown Data by Application

7 European Union

• 7.1 European Union Vasodilators Breakdown Data by Company
• 7.2 European Union Vasodilators Breakdown Data by Type
• 7.3 European Union Vasodilators Breakdown Data by Application

8 China

• 8.1 China Vasodilators Breakdown Data by Company
• 8.2 China Vasodilators Breakdown Data by Type
• 8.3 China Vasodilators Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Vasodilators Breakdown Data by Company
• 9.2 Rest of World Vasodilators Breakdown Data by Type
• 9.3 Rest of World Vasodilators Breakdown Data by Application
• 9.4 Rest of World Vasodilators Breakdown Data by Countries
  • 9.4.1 Rest of World Vasodilators Sales by Countries
  • 9.4.2 Rest of World Vasodilators Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Vasodilators
  • 10.1.4 Vasodilators Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 Novartis
  • 10.2.1 Novartis Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Vasodilators
  • 10.2.4 Vasodilators Product Introduction
  • 10.2.5 Novartis Recent Development
• 10.3 Merck
  • 10.3.1 Merck Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Vasodilators
  • 10.3.4 Vasodilators Product Introduction
  • 10.3.5 Merck Recent Development
• 10.4 Astra Zeneca
  • 10.4.1 Astra Zeneca Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Vasodilators
  • 10.4.4 Vasodilators Product Introduction
  • 10.4.5 Astra Zeneca Recent Development
• 10.5 Jhonson and Johnson
  • 10.5.1 Jhonson and Johnson Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Vasodilators
  • 10.5.4 Vasodilators Product Introduction
  • 10.5.5 Jhonson and Johnson Recent Development
• 10.6 Eli Lilly
  • 10.6.1 Eli Lilly Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Vasodilators
  • 10.6.4 Vasodilators Product Introduction
  • 10.6.5 Eli Lilly Recent Development
• 10.7 Sanofi
  • 10.7.1 Sanofi Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Vasodilators
  • 10.7.4 Vasodilators Product Introduction
  • 10.7.5 Sanofi Recent Development
• 10.8 Bristol-Myers Squibb
  • 10.8.1 Bristol-Myers Squibb Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Vasodilators
  • 10.8.4 Vasodilators Product Introduction
  • 10.8.5 Bristol-Myers Squibb Recent Development
• 10.9 Bayer
  • 10.9.1 Bayer Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Vasodilators
  • 10.9.4 Vasodilators Product Introduction
  • 10.9.5 Bayer Recent Development
• 10.10 GSK
  • 10.10.1 GSK Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Vasodilators
  • 10.10.4 Vasodilators Product Introduction
  • 10.10.5 GSK Recent Development
• 10.11 Teva Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Vasodilators Sales Channels
  • 11.2.2 Vasodilators Distributors
• 11.3 Vasodilators Customers

12 Market Forecast

• 12.1 Global Vasodilators Sales and Revenue Forecast 2019-2025
• 12.2 Global Vasodilators Sales Forecast by Type
• 12.3 Global Vasodilators Sales Forecast by Application
• 12.4 Vasodilators Forecast by Regions
  • 12.4.1 Global Vasodilators Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Vasodilators Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Vasodilators are medicines that dilate (widen) blood vessels, allowing blood to flow more easily through. Some act directly on the smooth muscle cells lining the blood vessels. Other have a central effect, and regulate blood pressure most likely through the vasomotor center located within the medulla oblongata of the brain.
In 2019, the market size of Vasodilators is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Vasodilators.

This report studies the global market size of Vasodilators, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Vasodilators sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Segment by Product Type
Arterial Dilators
Venous Dilators
Mixed Dilators

Market Segment by Application
Hypertension
Angina
Heart Failure

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Vasodilators status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Vasodilators manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Vasodilators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025